Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

The contributions of Dr. Kathleen K. Sulik to fetal alcohol spectrum disorders research and prevention.

Parnell SE, Riley EP, Warren KR, Mitchell KT, Charness ME.

Alcohol. 2018 Jun;69:15-24. doi: 10.1016/j.alcohol.2017.10.008. Epub 2018 Mar 20. Review.

PMID:
29571046
2.

Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities.

May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D, Kopald D, Hasken JM, Xu R, Honerkamp-Smith G, Taras H, Manning MA, Robinson LK, Adam MP, Abdul-Rahman O, Vaux K, Jewett T, Elliott AJ, Kable JA, Akshoomoff N, Falk D, Arroyo JA, Hereld D, Riley EP, Charness ME, Coles CD, Warren KR, Jones KL, Hoyme HE.

JAMA. 2018 Feb 6;319(5):474-482. doi: 10.1001/jama.2017.21896.

PMID:
29411031
3.

The adolescent brain cognitive development study external advisory board.

Charness ME.

Dev Cogn Neurosci. 2018 Aug;32:155-160. doi: 10.1016/j.dcn.2017.12.007. Epub 2017 Dec 28. Review. No abstract available.

4.

L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis.

Dou X, Menkari C, Mitsuyama R, Foroud T, Wetherill L, Hammond P, Suttie M, Chen X, Chen SY, Charness ME; Collaborative Initiative on Fetal Alcohol Spectrum Disorders.

FASEB J. 2018 Mar;32(3):1364-1374. doi: 10.1096/fj.201700970. Epub 2018 Jan 3.

PMID:
29109170
5.

Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders.

Hoyme HE, Kalberg WO, Elliott AJ, Blankenship J, Buckley D, Marais AS, Manning MA, Robinson LK, Adam MP, Abdul-Rahman O, Jewett T, Coles CD, Chambers C, Jones KL, Adnams CM, Shah PE, Riley EP, Charness ME, Warren KR, May PA.

Pediatrics. 2016 Aug;138(2). pii: e20154256. doi: 10.1542/peds.2015-4256. Epub 2016 Jul 27.

6.

Drinking During Pregnancy and the Developing Brain: Is Any Amount Safe?

Charness ME, Riley EP, Sowell ER.

Trends Cogn Sci. 2016 Feb;20(2):80-82. doi: 10.1016/j.tics.2015.09.011.

7.

Effect of lipid raft disruption on ethanol inhibition of l1 adhesion.

Dou X, Charness ME.

Alcohol Clin Exp Res. 2014 Nov;38(11):2707-11. doi: 10.1111/acer.12556.

8.

Pregnancy: No safe level of alcohol.

Sowell ER, Charness ME, Riley EP.

Nature. 2014 Sep 11;513(7517):172. doi: 10.1038/513172c. No abstract available.

PMID:
25209788
9.

Brain surgery for musician's dystonia.

Charness ME.

Ann Neurol. 2013 Nov;74(5):627-9. doi: 10.1002/ana.23975. Epub 2013 Sep 10. No abstract available.

PMID:
23893466
10.

Mitogen-activated protein kinase modulates ethanol inhibition of cell adhesion mediated by the L1 neural cell adhesion molecule.

Dou X, Wilkemeyer MF, Menkari CE, Parnell SE, Sulik KK, Charness ME.

Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5683-8. doi: 10.1073/pnas.1221386110. Epub 2013 Feb 19.

11.

Ethanol disrupts axon outgrowth stimulated by netrin-1, GDNF, and L1 by blocking their convergent activation of Src family kinase signaling.

Chen S, Charness ME.

J Neurochem. 2012 Nov;123(4):602-12. doi: 10.1111/j.1471-4159.2012.07954.x. Epub 2012 Sep 28. Retraction in: J Neurochem. 2015 Mar;132(6):756.

12.

Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1.

Fitzgerald DM, Charness ME, Leite-Morris KA, Chen S.

PLoS One. 2011;6(9):e24364. doi: 10.1371/journal.pone.0024364. Epub 2011 Sep 8.

13.

How Should Addiction-Related Research at the National Institutes of Health be Reorganized?

Johnson BA, Messing RO, Charness ME, Crabbe JC, Goldman MS, Harris RA, Kranzler HR, Mitchell MC Jr, Nixon SJ, Riley EP, Schuckit MA, Sher KJ, Thomas JD.

Front Psychiatry. 2011 May 3;2:2. doi: 10.3389/fpsyt.2011.00002. eCollection 2011. No abstract available.

14.

Should the reorganization of addiction-related research across all the National Institutes of Health be structural?--The devil is truly in the details.

Johnson BA, Messing RO, Charness ME, Crabbe JC, Goldman MS, Harris RA, Kranzler HR, Mitchell MC Jr, Nixon SJ, Riley EP, Schuckit MA, Sher KJ, Thomas JD.

Alcohol Clin Exp Res. 2011 Apr;35(4):572-80. doi: 10.1111/j.1530-0277.2011.01493.x.

15.

Two alcohol binding residues interact across a domain interface of the L1 neural cell adhesion molecule and regulate cell adhesion.

Dou X, Menkari CE, Shanmugasundararaj S, Miller KW, Charness ME.

J Biol Chem. 2011 May 6;286(18):16131-9. doi: 10.1074/jbc.M110.209254. Epub 2011 Mar 2.

16.

Ethanol inhibits neuronal differentiation by disrupting activity-dependent neuroprotective protein signaling.

Chen S, Charness ME.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19962-7. doi: 10.1073/pnas.0807758105. Epub 2008 Dec 1.

17.

An alcohol binding site on the neural cell adhesion molecule L1.

Arevalo E, Shanmugasundararaj S, Wilkemeyer MF, Dou X, Chen S, Charness ME, Miller KW.

Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):371-5. doi: 10.1073/pnas.0707815105. Epub 2007 Dec 28.

18.

Concurrent dietary administration of D-SAL and ethanol diminishes ethanol's teratogenesis.

Parnell SE, Chen SY, Charness ME, Hodge CW, Dehart DB, Sulik KK.

Alcohol Clin Exp Res. 2007 Dec;31(12):2059-64. Epub 2007 Oct 19.

PMID:
17949468
19.

Maternal oral intake mouse model for fetal alcohol spectrum disorders: ocular defects as a measure of effect.

Parnell SE, Dehart DB, Wills TA, Chen SY, Hodge CW, Besheer J, Waage-Baudet HG, Charness ME, Sulik KK.

Alcohol Clin Exp Res. 2006 Oct;30(10):1791-8.

PMID:
17010146
20.

Synergistic effects of the peptide fragment D-NAPVSIPQ on ethanol inhibition of synaptic plasticity and NMDA receptors in rat hippocampus.

Zhang TA, Hendricson AW, Wilkemeyer MF, Lippmann MJ, Charness ME, Morrisett RA.

Neuroscience. 2005;134(2):583-93.

PMID:
15963648
21.

Peptide-mediated protection from ethanol-induced neural tube defects.

Chen SY, Charness ME, Wilkemeyer MF, Sulik KK.

Dev Neurosci. 2005 Jan-Feb;27(1):13-9.

PMID:
15886480
22.

Ethanol antagonist peptides: structural specificity without stereospecificity.

Wilkemeyer MF, Chen SY, Menkari CE, Sulik KK, Charness ME.

J Pharmacol Exp Ther. 2004 Jun;309(3):1183-9. Epub 2004 Feb 4.

23.

Brain mapping in musicians with focal task-specific dystonia.

Charness ME, Schlaug G.

Adv Neurol. 2004;94:231-8. Review. No abstract available.

PMID:
14509678
24.

Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity.

Wilkemeyer MF, Chen SY, Menkari CE, Brenneman DE, Sulik KK, Charness ME.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8543-8. Epub 2003 Jun 13.

25.

A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia.

Simon DK, Friedman J, Breakefield XO, Jankovic J, Brin MF, Provias J, Bressman SB, Charness ME, Tarsy D, Johns DR, Tarnopolsky MA.

Neurogenetics. 2003 Aug;4(4):199-205. Epub 2003 May 17.

PMID:
12756609
26.

Prenatal alcohol exposure: advancing knowledge through international collaborations.

Riley EP, Guerri C, Calhoun F, Charness ME, Foroud TM, Li TK, Mattson SN, May PA, Warren KR.

Alcohol Clin Exp Res. 2003 Jan;27(1):118-35.

PMID:
12544016
27.

Novel antagonists of alcohol inhibition of l1-mediated cell adhesion: multiple mechanisms of action.

Wilkemeyer MF, Menkari CE, Charness ME.

Mol Pharmacol. 2002 Nov;62(5):1053-60.

28.

Peptide antagonists of ethanol inhibition of l1-mediated cell-cell adhesion.

Wilkemeyer MF, Menkari CE, Spong CY, Charness ME.

J Pharmacol Exp Ther. 2002 Oct;303(1):110-6.

29.

Octanol antagonism of ethanol teratogenesis.

Chen SY, Wilkemeyer MF, Sulik KK, Charness ME.

FASEB J. 2001 Jul;15(9):1649-51. No abstract available.

PMID:
11427515
30.

The GAG deletion of the DYT1 gene is infrequent in musicians with focal dystonia.

Friedman JR, Klein C, Leung J, Woodward H, Ozelius LJ, Breakefield XO, Charness ME.

Neurology. 2000 Nov 14;55(9):1417-8. No abstract available.

PMID:
11087801
31.

Sleep and wakefulness in c-fos and fos B gene knockout mice.

Shiromani PJ, Basheer R, Thakkar J, Wagner D, Greco MA, Charness ME.

Brain Res Mol Brain Res. 2000 Aug 14;80(1):75-87.

PMID:
11039731
32.

Antagonists of alcohol inhibition of cell adhesion.

Wilkemeyer MF, Sebastian AB, Smith SA, Charness ME.

Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3690-5.

33.

Intracranial voyeurism: revealing the mammillary bodies in alcoholism.

Charness ME.

Alcohol Clin Exp Res. 1999 Dec;23(12):1941-4. Review. No abstract available.

PMID:
10630614
34.

Alcohol inhibition of cell adhesion in BMP-treated NG108-15 cells.

Wilkemeyer MF, Pajerski M, Charness ME.

Alcohol Clin Exp Res. 1999 Nov;23(11):1711-20.

PMID:
10591586
35.
36.

Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis.

Perides G, Charness ME, Tanner LM, P├ęter O, Satz N, Steere AC, Klempner MS.

J Infect Dis. 1998 Feb;177(2):401-8.

PMID:
9466528
37.

Treatment of occupational cramp with botulinum toxin: diffusion of toxin to adjacent noninjected muscles.

Ross MH, Charness ME, Sudarsky L, Logigian EL.

Muscle Nerve. 1997 May;20(5):593-8.

PMID:
9140366
38.

Evaluation of suspected dementia.

Charness ME.

N Engl J Med. 1996 Dec 26;335(26):1996-7; author reply 1997-8. No abstract available.

PMID:
8975128
39.

Direct effects of ethanol on signaling proteins.

Charness ME.

Alcohol Clin Exp Res. 1996 Nov;20(8 Suppl):157A-161A. No abstract available.

PMID:
8947256
40.

Ulnar neuropathy and dystonic flexion of the fourth and fifth digits: clinical correlation in musicians.

Charness ME, Ross MH, Shefner JM.

Muscle Nerve. 1996 Apr;19(4):431-7.

PMID:
8622720
41.

Alcohol inhibits cell-cell adhesion mediated by human L1.

Ramanathan R, Wilkemeyer MF, Mittal B, Perides G, Charness ME.

J Cell Biol. 1996 Apr;133(2):381-90. Erratum in: J Cell Biol 1996 Jun;133(5):1139-40.

42.

Haplotype analysis at the DYT1 locus in Ashkenazi Jewish patients with occupational hand dystonia.

Gasser T, Bove CM, Ozelius LJ, Hallett M, Charness ME, Hochberg FH, Breakefield XO.

Mov Disord. 1996 Mar;11(2):163-6.

PMID:
8684386
43.

Does ulnar neuropathy predispose to focal dystonia?

Ross MH, Charness ME, Lee D, Logigian EL.

Muscle Nerve. 1995 Jun;18(6):606-11.

PMID:
7753123
44.

Time course of phosphorylated CREB and Fos-like immunoreactivity in the hypothalamic supraoptic nucleus after salt loading.

Shiromani PJ, Magner M, Winston S, Charness ME.

Brain Res Mol Brain Res. 1995 Mar;29(1):163-71.

PMID:
7769993
45.

Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia.

Perides G, Jensen FE, Edgecomb P, Rueger DC, Charness ME.

Neurosci Lett. 1995 Feb 24;187(1):21-4.

PMID:
7617293
46.

Ethanol inhibits neural cell-cell adhesion.

Charness ME, Safran RM, Perides G.

J Biol Chem. 1994 Mar 25;269(12):9304-9.

47.

Limb dystonia following electrical injury.

Tarsy D, Sudarsky L, Charness ME.

Mov Disord. 1994 Mar;9(2):230-2.

PMID:
8196690
48.

Idiopathic striopallidodentate calcification with prominent supranuclear abnormality of eye movement.

Saver JL, Liu GT, Charness ME.

J Neuroophthalmol. 1994 Mar;14(1):29-33.

PMID:
8032477
50.

Ethanol increases delta-opioid receptor gene expression in neuronal cell lines.

Charness ME, Hu G, Edwards RH, Querimit LA.

Mol Pharmacol. 1993 Dec;44(6):1119-27.

PMID:
8264548

Supplemental Content

Loading ...
Support Center